Nicholas Hugh Meryon Insall

Part of Takeda Pharmaceutical Co., Ltd., Shire Pharmaceuticals Group is a British company that manufactures and distributes pharmaceutical products. The company is based in London, UK.

Viropharma Ltd. manufactures pharmaceutical products. The company was founded on May 14, 2007 and is headquartered in London, the United Kingdom.

Part of Takeda Pharmaceutical Co., Ltd., Shire Europe Ltd. is a holding British company that oversees the manufacturing and wholesale distribution of pharmaceutical medicines. The company is based in London, UK.

Founded in 2003, Shire Holdings UK Ltd. is a subsidiary of Takeda Pharmaceutical Co., Ltd. and functions as an investment holding company. The company is based in London, UK.

Founded in 2005, Shire Biopharmaceuticals Holdings is an investment holding British company that is part of Takeda Pharmaceutical Co., Ltd. The company is based in London, UK.

Founded in 1997, Proactiv Skin Health Ltd. is a part of Guthy-Renker Partners, Inc. that provides sales and support services. The company is based in London, UK.

Evotec International GmbH develops and provides drugs for the treatment of CNS disorders. It focuses on Alzheimer's disease and other neurological disorders. The company was founded in 1999 and is headquartered in Hamburg, Germany.

Galderma Holding SA owns shares and interest of manufacturers and distributors of dermatological and skin care products. The company is headquartered in La Tour-de-Peilz, Swtzerland.

Part of Galderma Pharma SA, Galderma SA is a Swiss company that manufactures and distributes dermatology products. The company is based in Lausanne, Switzerland.

Part of Dolder Bigler AG, Dolder AG is a Swiss company that specializes in producing high-quality plastics and specialty chemicals. The company is based in Basel, Switzerland and works with other industry leaders such as Coim, Eastman, Evonik, and Huntsman to provide top-of-the-line products for their customers. The company's laripur® tpu and ™ copolyester products are used for injection molding and extrusion, and offer a soft touch effect and higher heat and chemical resistance than other materials.

Part of Takeda Pharmaceutical Co., Ltd., Shire Global Finance is a British financial services company founded in 2005. The company is based in London, UK. Shire Global Finance offers financial services.

Part of Takeda Pharmaceutical Co., Ltd., Shire Biotech UK Holdings Ltd. is an investment holding company. Shire Biotech UK Holdings Ltd. is based in London, UK. Founded in 2017, Shire Biotech UK Holdings functions as an investment holding company.

Part of Takeda Pharmaceutical Co., Ltd., NPS Pharma UK Ltd. is a company that develops and markets medicines for patients with rare diseases. The company is based in London, UK and was founded in 2006.

Astion Pharma A/S develops and manufactures pharmaceutical products. It focuses on developing anti-inflammatory drugs for dermatological and immunological diseases. The company was founded by Morten S. Weidner in 1992 and is headquartered in Copenhagen, Denmark.

Credit Suisse Securities (Europe) Ltd. (Credit Suisse Europe) is the Great Britain-based brokerage subsidiary of Credit Suisse Investment Holdings (UK), itself a subsidiary of Credit Suisse Group AG (SWX: CSGN) in Switzerland. The firm was founded in 1966 and formerly known as Credit Suisse First Boston (Europe) Ltd. Headquartered in London, Credit Suisse Europe arranges financing in international capital markets, provides financial advisory services and acts as a dealer in securities, derivatives and foreign exchange on a principal and agency basis for corporate and institutional investors.

Roche Innovation Center Copenhagen A/S discovers and develops drugs for the treatment of oncology, metabolic diseases, and infectious diseases. The firm manufactures a pipeline of drug candidates that act selectively on disease-related ribonucleic acid to provide patients with novel treatments for both rare and common diseases. It produces pre-clinical and clinical assets for the treatment of a range of diseases including oncology, metabolic diseases, and infectious diseases. The company was founded by Matts Lundwall and Mikael Ørum on January 1, 1998 and is headquartered in Horsholm, Denmark.

Bausch & Lomb, Inc. develops, manufactures, and markets eye health products. It offers over-the-counter supplements, eye care products, ophthalmic pharmaceuticals, contact lenses, lens care, ophthalmic surgical devices, and instruments. The company was founded by John Jacob Bausch and Henry Lomb in 1853 and is headquartered in Rochester, NY.

Galderma Pharma SA discovers, develops, and markets therapeutic, corrective, and aesthetic solutions. It offers drugs, medical dermatology solutions, and therapeutic skin care products for treating hair, nail, and skin diseases. The company was founded in 1981 and is headquartered in Lausanne, Switzerland.

Bayer Pharma AG engages in the development and production of prescription drugs for the treatment of cardiovascular diseases and women's illnesses, as well as special therapy in the areas of oncology, hematology, and ophthalmology. It also offers medical equipment used in diagnostic imaging with applications in the field of radiology. The company was founded on March 9, 1965 and is headquartered in Berlin, Germany.

Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers.

Swiss-American Chamber of Commerce is an organization that advocates for Swiss, American, and multinational business interests. The non-profit company is based in Zurich, Switzerland. The Swiss company is active in all three major regions of Switzerland, organizing events and conducting comprehensive studies on business-related topics. The organization's special committees provide valuable input into its operations, and its flagship publication, the Yearbook, contains a member directory and a comprehensive collection of facts and figures on Swiss-U.S. business relations. Martin M. Naville has been the CEO of the company since 2004.

Centogene AG focuses on genetic and biochemical diagnostic testing services for rare hereditary disorders. The firm operates through the offices located in Freiburg, Dubai and Noida. The company was founded by Arndt Rolfs in 2006 and is headquartered in Rostock, Germany.